
May 27 (Reuters) - Novartis AG NOVN.S:
NOVARTIS ANNOUNCES COMMENCEMENT OF TENDER OFFER TO ACQUIRE REGULUS THERAPEUTICS
NOVARTIS AG - OFFER INCLUDES $7.00 CASH PER SHARE PLUS CONTINGENT VALUE RIGHT
NOVARTIS AG - PAR VALUE $0.001 PER SHARE
NOVARTIS AG - OFFER SUBJECT TO CUSTOMARY CONDITIONS INCLUDING HART-SCOTT-RODINO ACT
NOVARTIS AG - IN EXCHANGE FOR (I) $7.00 IN CASH PER SHARE
NOVARTIS AG - OFFER WILL EXPIRE AT ONE MINUTE PAST 11:59 P.M., NEW YORK CITY TIME, ON JUNE 24, 2025, UNLESS OFFER IS OTHERWISE EXTENDED OR EARLIER TERMINATED